Carotid Artery Stenting With Protection Registry
Treatment of Carotid Stenosis With Carotid Stenting and Neurologic Protection With Pre-Procedure and Follow-Up With MRI DIffusion Imaging and Neuropsychological Testing
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Washington
-
Spokane, Washington, United States, 99204
- Sacred Heart Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age greater than 18 and less than 90
- Symptomatic as evidenced by transient ischemic attack or non-disabling stroke in the hemisphere supplied by the target vessel within 180 days of procedure. Must have anatomic stenosis greater than 70% by ultrasound or angiography performed in previous 30 days
- Asymptomatic patients with a stenosis greater than 80% by ultrasound or angiography performed in previous 30 days
- Patient has no childbearing potential or has negative pregnancy tests within one week prior to procedure.
- Patient and patient's physician agree to have the patient return for all the required clinical contacts following study enrollment
- Patient signs informed consent
- Patient has been excluded from other multi-institutional trials
Exclusion Criteria:
- Patient has evolving stroke or intracranial hemorrhage
- Allergy to trial required medications
- Active bleeding diathesis or coagulopathy, or will refuse blood transfusions
- History of major ipsilateral stroke with sufficient atrophy to increase risk of procedure associated bleed
- Severe dementia
- Previous intracranial hemorrhage or brain surgery within the past twelve months
- Patient has any condition that precludes angiography or would make a percutaneous procedure unsafe
- Patient or family inability to understand or cooperate with study procedures
- Recent GI or remote bleed that would interfere with anti-plate therapy
- Severe vessel tortuosity or calcification that would preclude introduction of guiding catheter, guiding sheath, or stent placement
- Extensive diffuse atherosclerotic disease involving the arch or common carotid that would preclude safe introduction of catheters and sheaths for endovascular therapy
- Intraluminal filling defect
- Intracranial aneurysm greater than 6 mm, AVM, or other intracranial vascular abnormality that would preclude safe intravascular intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Carotid Artery Stenting
|
Carotid Stent Placement with Distal Protection
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of new diffusion weighted abnormalities post-procedure
Time Frame: 24 hours post stent placement
|
24 hours post stent placement
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Neuropsychological stability or deterioration
Time Frame: 3 months post procedure
|
3 months post procedure
|
|
Neuropsychological stability or deterioration
Time Frame: 6 months post procedure
|
6 months post procedure
|
|
Neuropsychological stability or deterioration
Time Frame: 12 months post procedure
|
12 months post procedure
|
|
Acute versus delayed neuropsychological changes
Time Frame: 1-7 days post procedure
|
1-7 days post procedure
|
|
Acute versus delayed neuropsychological changes
Time Frame: 3 months post procedure
|
3 months post procedure
|
|
Acute versus delayed neuropsychological changes
Time Frame: 6 months post procedure
|
6 months post procedure
|
|
Acute versus delayed neuropsychological changes
Time Frame: 12 months post procedure
|
12 months post procedure
|
|
Stroke and death
Time Frame: 1 month
|
1 month
|
|
Stroke and death
Time Frame: 6 months
|
6 months
|
|
Stroke and death
Time Frame: 12 months
|
12 months
|
|
NIH stroke scale changes
Time Frame: 24 hours post procedure
|
24 hours post procedure
|
|
NIH stroke scale changes
Time Frame: 1 month post procedure
|
1 month post procedure
|
|
NIH stroke scale changes
Time Frame: 6 months post procedure
|
6 months post procedure
|
|
NIH stroke scale changes
Time Frame: 12 months post procedure
|
12 months post procedure
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Rodney D. Raabe, MD, Providence Health & Services
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HI473
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.